Industry
Testing On Tissues and Cells Sector Reaches USD 7.5 Billion
Driven by new technologies and the need to discover biomarkers, the tissue and cell-based diagnostic market grew to an estimated USD 7.4 billion in revenues in 2013 for in vitro diagnostic and other reagents used by clinical laboratories, according to a new report from Kalorama Information. More...05 Jan 2015

Bacterial Infection Assay Receives First Simultaneous FDA Clearance and CLIA Waiver
A Group A Streptococcus diagnostic test from Quidel Corporation has received the first-ever simultaneous FDA clearance and CLIA waiver via the new, time- and cost-saving Dual Submission Program of the United States Food and Drug Administration. More...04 Jan 2015
Strong Growth Forecasted for Women's Health Diagnostics
Key women's health diagnostics are showing strong growth worldwide, according to healthcare market researcher Kalorama Information, including, among others, the sectors for digital mammography, lab-based fertility testing, and bone densitometry. More...28 Dec 2014
Merger Expected to Accelerate Development of Personalized Medicine Solutions
Acquisition of an American company specializing in data management and analysis by a worldwide leader in genomics research and diagnostics development is expected to decrease the complexity, time, and cost of genomic analysis and accelerate development of the science of personalized medicine. More...28 Dec 2014
Diagnostics Rapidly Gain Ground in Infectious Diseases Sector
According to a new Frost & Sullivan analysis, convergence of immunological and molecular tests will help meet growing needs for infectious disease diagnostics. Although these tests remain expensive, their efficiency and accuracy strengthen their use case. More...22 Dec 2014
Robot-Assisted PCR Among Innovations Driving qPCR Sector
Seeking efficiency in the qPCR process, a number of automation and robotics technologies have been added to product offerings from top competitors. According to the new Kalorama Information report “qPCR and dPCR Markets: Clinical and Research Markets,” this is one factor driving the usefulness of this workhorse lab technology. More...21 Dec 2014
Roche Acquires High-Precision Dissection Technology from AvanSci Bio
Roche Diagnostics of the Roche group has signed a definitive Asset Purchase Agreement with AvanSci Bio for all products associated with the high-performance microdissection of slide-mounted tissue sections for subsequent molecular analysis. More...15 Dec 2014
In Other News
Ferring and Roche Collaborate on Personalized Infertility Treatment
Roche Enters Additional Sectors with Acquisition of Ariosa
Physician Office Testing Found Responsive to Developing World Needs
Foundations Fund Fast-Track Development of Ebola Test
TESARO and Myriad Expand Collaboration with New CDx Pair
Women’s Health Diagnostics Grows to USD 8 Billion Sector
Oncology Companion Diagnostics Sector Grows to Over USD 1 Billion
Collaboration to Bring Personalized Cancer Care to Singapore
Market for qPCR Exceeds USD 3 Billion
Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary
Aperiomics Launches Novel NGS Services
Distribution Agreement Will Streamline Methotrexate Determinations
Blood Sector Continues to Experience Solid Growth
Partners to Develop Rapid Ebola Point-of-Care Test
Tumor BRAC Analysis CDx Lab Established in Europe
Ventana to Develop Companion Diagnostics for ImmunoGen Anticancer Agents
ERBA Diagnostics Enters Brazilian Sector with Leading-Edge Clinical Testing Portfolio
French-German Cooperation to Improve Personalized Cancer Care
BD Advances Entry into NGS with Acquisition of GenCell Biosystems
GlaxoSmithKline Boosts Global Cancer Testing With GE Healthcare Deal
Emergency Approval of Ebola Test Suggests Opportunity for Test Makers
EKF and Mass. General Collaborate to Develop Blood Tests for Cancer Patients
Merck KGaA to Buy Sigma-Aldrich for USD 17 Billion
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.







